Lucintel's latest market report analyzed that in situ hybridization provides attractive opportunities in fluorescent in the research & diagnostic laboratory, CRO, and academic institute end use industries. The in situ hybridization market is expected to reach $2.4 billion by 2028 with a CAGR of 9.4%. In this market, fluorescent in situ hybridization (FISH) is the largest segment by technology, whereas research & diagnostic laboratories is largest by end use industry.
Download Brochure of this report by clicking on https://www.lucintel.com/in-situ-hybridization-market.aspx
Based on technology, the in situ hybridization market is segmented into fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). The fluorescent in situ hybridization (FISH) segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, because it provides researchers with a method to visualize and map the genetic components in a single cell.
Browse in-depth TOC on “In Situ Hybridization Market”
100 – Figures/Tables
150 – Pages
The In Situ Hybridization Market is marked by the presence of several big and small players. Some of the prominent players offering in situ hybridization include Thermo Fisher Scientific, Abbott, PerkinElmer, BioView, and Agilent Technologies.
Request Sample Report:
https://www.lucintel.com/in-situ-hybridization-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.